Lorna Jane, an Australian activewear company, was recently fined AU$5 million after claiming that its new line of active clothing can stop the spread of COVID-19. The firm said that its clothing could eliminate the virus, thus preventing its spread.
According to BBC News, Lorna Jane released advertisements that say it is using a groundbreaking technology called LJ Shield for its clothing line. It was claimed that this could stop the "transfer of all pathogens."
What the court says on Lorna Jane’s claims
Based on the report, a judge said in a ruling that the company’s claim about LJ Shield is "exploitative, predatory and potentially dangerous." The legal action against Lorna Jane was filed by the Australian Competition & Consumer Commission (ACCC) after the firm started selling its clothing in July amid the COVID-19 pandemic.
The verdict was said to have been released by the federal court on Friday, July 23. The judge said that based on investigations, Lorna Jane has been telling the consumers it has a “reasonable scientific or technological basis" for its claims about its clothing with the LJ Shield.
However, the judge said there was actually no scientific basis for such a claim. For this false and misleading representation to the public, the court slapped the company with a hefty fine.
"This was dreadful conduct as it involved making serious claims regarding public health when there was no basis for them," chairman of the ACCC, Rod Sims, said. "The whole marketing campaign was based upon consumers' desire for greater protection against the global pandemic."
Lorna Jane accepts the judge’s decision
The company was said to have accepted the verdict but explained, it was also misled by its supplier. Lorna Jane claimed its supplier sold them a product that did not deliver what it claimed to be, and they are referring to what they called the LJ Shield technology that is supposed to be anti-viral and anti-bacterial.
Meanwhile, it was learned that this is not the first time that Lorna Jane was fined. As per The Guardian, just in July 2020, the company was fined $40,000 for its failure to seek proper approval for ads from the Therapeutic Goods Administration. As for this new issue, the company issued an apology for its customers while continuing to blame its supplier for the issue.


Proposed Rio Tinto–Glencore Merger Faces China Regulatory Hurdles and Asset Sale Pressure
Asian Markets Slip as Precious Metals Cool, Geopolitical Tensions Weigh on Sentiment
Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation
Lululemon Founder Chip Wilson Escalates Proxy Fight to Remove Advent From Board
Forex Markets Hold Steady as Traders Await Fed Minutes Amid Thin Year-End Volumes
USDA $12 Billion Farm Aid Program Draws Mixed Reactions from Row Crop Farmers
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years
South Korea Inflation Rises to 2.3% in December, Matching Market Expectations
Asian Currencies Trade Flat as Dollar Weakens in Thin New Year Trading
Trump Criticizes NYSE Texas Expansion, Calls Dallas Exchange a Blow to New York
United Airlines Posts Record Q4 Revenue as Premium Demand Lifts Earnings
Oil Prices Slide in 2025 as Oversupply and Geopolitical Risks Shape Market Outlook
Valentino Garavani Dies at 93, Leaving Behind the Timeless Legacy of Valentino Red
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates
Nvidia CEO Jensen Huang Plans China Visit Amid AI Chip Market Uncertainty 



